title: A placebo-controlled clinical phase I trial with combined anti-HIV-1 and anti-interferon-alpha immunization.
authors.forename: I P
authors.initials: IP
authors.lastname: Coulaud
authors.forename: M L
authors.initials: ML
authors.lastname: Gougeon
authors.forename: E
authors.initials: E
authors.lastname: Gomard
authors.forename: D
authors.initials: D
authors.lastname: Descamps
authors.forename: P
authors.initials: P
authors.lastname: Lebon
authors.forename: J P
authors.initials: JP
authors.lastname: Aboulker
authors.forename: B
authors.initials: B
authors.lastname: Bizzini
authors.forename: D
authors.initials: D
authors.lastname: Zagury
mesh_terms: D016915:AIDS Vaccines / Q000276:immunology / Q000627:therapeutic use*; D004311:Double-Blind Method; D004338:Drug Combinations; D015658:HIV Infections / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007370:Interferon Type I / Q000276:immunology / Q000627:therapeutic use*; D010455:Peptides / Q000276:immunology / Q000627:therapeutic use; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic / Q000627:therapeutic use*
chemical_list: D016915:AIDS Vaccines; D004338:Drug Combinations; D007370:Interferon Type I; D010455:Peptides; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic